|
1
|
Parker SR and MacKelfresh J: Autoimmune
blistering diseases in the elderly. Clin Dermatol. 29:69–79.
2011.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Bernard P and Antonicelli F: Bullous
pemphigoid: A review of its Diagnosis, Associations and Treatment.
Am J Clin Dermatol. 18:513–528. 2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Miyamoto D, Santi CG, Aoki V and Maruta
CW: Bullous pemphigoid. An Bras Dermatol. 94:133–146.
2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Patel F, Wilken R, Patel FB, Sultani H,
Bustos I, Duong C, Zone JJ, Raychaudhuri SP and Maverakis E:
Pathophysiology of autoimmune bullous diseases: Nature versus
nurture. Indian J Dermatol. 62:262–267. 2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Yang M, Wu H, Zhao M, Chang C and Lu Q:
The pathogenesis of bullous skin diseases. J Transl Autoimmun.
2(100014)2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Marazza G, Pham HC, Schärer L, Pedrazzetti
PP, Hunziker T, Trüeb RM, Hohl D, Itin P, Lautenschlager S, Naldi
L, et al: Incidence of bullous pemphigoid and pemphigus in
Switzerland: A 2-year prospective study. Br J Dermatol.
161:861–868. 2009.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Langan SM, Smeeth L, Hubbard R, Fleming
KM, Smith CJ and West J: Bullous pemphigoid and pemphigus
vulgaris-incidence and mortality in the UK: Population based cohort
study. BMJ. 337(a180)2008.PubMed/NCBI View
Article : Google Scholar
|
|
8
|
Gudi VS, White MI, Cruickshank N, Herriot
R, Edwards SL, Nimmo F and Ormerod AD: Annual incidence and
mortality of bullous pemphigoid in the Grampian Region of
North-east Scotland. Br J Dermatol. 153:424–427. 2005.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Hübner F, Recke A, Zillikens D, Linder R
and Schmidt E: Prevalence and age distribution of pemphigus and
pemphigoid diseases in Germany. J Invest Dermatol. 136:2495–2498.
2016.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Feliciani C, Caldarola G, Kneisel A,
Podstawa E, Pfütze M, Pfützner W and Hertl M: IgG autoantibody
reactivity against bullous pemphigoid (BP) 180 and BP230 in elderly
patients with pruritic dermatoses. Br J Dermatol. 161:306–312.
2009.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Hopkinson SB and Jones JC: The N terminus
of the transmembrane protein BP180 interacts with the N-terminal
domain of BP230, thereby mediating keratin cytoskeleton anchorage
to the cell surface at the site of the hemidesmosome. Mol Biol
Cell. 11:277–286. 2000.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Giang J, Seelen MAJ, van Doorn MBA,
Rissmann R, Prens EP and Damman J: Complement activation in
inflammatory skin diseases. Front Immunol. 9(639)2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Fania L, Caldarola G, Müller R, Brandt O,
Pellicano R, Feliciani C and Hertl M: IgE recognition of bullous
pemphigoid (BP)180 and BP230 in BP patients and elderly individuals
with pruritic dermatoses. Clin Immunol. 143:236–245.
2012.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Di Zenzo G, Thoma-Uszynski S, Fontao L,
Calabresi V, Hofmann SC, Hellmark T, Sebbag N, Pedicelli C, Sera F,
Lacour JP, et al: Multicenter prospective study of the humoral
autoimmune response in bullous pemphigoid. Clin Immunol.
128:415–426. 2008.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Park SH, Lee SH, Kim JH and Kim SC:
Circulating eosinophil and neutrophil counts correlate with disease
severity in bullous pemphigoid. Ann Dermatol. 30:544–549.
2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Budamagunta V, Foster TC and Zhou D:
Cellular senescence in lymphoid organs and immunosenescence. Aging
(Albany NY). 13:19920–19941. 2021.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Liu YD, Wang YH, Ye YC, Zhao WL and Li L:
Prognostic factors for mortality in patients with bullous
pemphigoid: a meta-analysis. Arch Dermatol Res. 309:335–347.
2017.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Lai YC, Yew YW and Lambert WC: Bullous
pemphigoid and its association with neurological diseases: A
systematic review and meta-analysis. J Eur Acad Dermatology
Venereol. 30:2007–2015. 2016.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Adam J, Pichler WJ and Yerly D: Delayed
drug hypersensitivity: Models of T-cell stimulation. Br J Clin
Pharmacol. 71:701–707. 2011.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Ruocco V, Satriano RA and Guerrera V:
‘Two-step’ pemphigus induction by ACE-inhibitors. Int J Dermatol.
31:33–36. 1992.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Ruocco V and Sacerdoti G: Pemphigus and
Bullous pemphigoid due to drugs. Int J Dermatol. 30:307–312.
1991.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Faina V, Sernicola A, Russo I, Michelotto
A, Szathvary V, Frigo AC and Alaibac M: Programmed cell death-1
rs2227981 polymorphism in patients with autoimmune skin blistering
disorders: A pilot study. Meta Gene. 26(100793)2020.
|
|
23
|
Stavropoulos PG, Soura E and Antoniou C:
Drug-induced pemphigoid: A review of the literature. J Eur Acad
Dermatology Venereol. 28:1133–1140. 2014.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Lo Schiavo A, Ruocco E, Brancaccio G,
Caccavale S, Ruocco V and Wolf R: Bullous pemphigoid: Etiology,
pathogenesis, and inducing factors: Facts and controversies. Clin
Dermatol. 31:391–399. 2013.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Drago F, Nozza P, Casazza S, Brusati C,
Bandelloni R and Rebora A: Human herpesviruses in bullous
pemphigoid lesions. Br J Dermatol. 152:375–376. 2005.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Iriki H, Adachi T, Matsuda H, Chinen K,
Arakawa H, Yamagami J, Nishie W and Yokouchi M: Case of dipeptidyl
peptidase 4 inhibitor-associated bullous pemphigoid that developed
after a scabies infestation. J Dermatol. 47:e258–e260.
2020.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Mai Y, Nishie W, Sato K, Hotta M, Izumi K,
Ito K, Hosokawa K and Shimizu H: Bullous pemphigoid triggered by
thermal burn under medication with a dipeptidyl peptidase-IV
inhibitor: A case report and review of the literature. Front
Immunol. 9(542)2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Vassileva S: Drug-induced pemphigoid:
Bullous and cicatricial. Clin Dermatol. 16:379–387. 1998.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Dănescu S, Chiorean R, Macovei V, Sitaru C
and Baican A: Role of physical factors in the pathogenesis of
bullous pemphigoid: Case report series and a comprehensive review
of the published work. J Dermatol. 43:134–140. 2016.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Caca-Biljanovska N, Arsovska-Bezhoska I
and V'lckova-Laskoska M: PUVA-induced bullous pemphigoid in
psoriasis. Acta Dermatovenerol Croat. 24:214–217. 2016.PubMed/NCBI
|
|
31
|
Perl S, Rappersberger K, Födinger D, Anegg
B, Hönigsmann H and Ortel B: Bullous pemphigoid induced by PUVA
therapy. Dermatology. 193:245–247. 1996.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Preesman AH, Toonstra J, Van der Putte SC,
De Geer DB, Van Weelden H and Van Vloten WA: UV-B-induced bullous
pemphigoid restricted to mycosis fungoides plaques. Clin Exp
Dermatol. 15:363–366. 1990.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Korekawa A, Kaneko T, Nakajima K, Rokunohe
D, Akasaka E, Nakano H, Sawamura D, Fukui T, Takiyoshi N, Kitamura
H and Harada K: Mycosis fungoides bullosa associated with bullous
pemphigoid. Int J Dermatol. 54:e366–e368. 2015.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Mitsuhashi Y, Nakano H, Murai T, Ohta T,
Sawamura D, Hanada K and Hashimoto I: Bullous pemphigoid sera
induce bullous-pemphigoid-like lesions in neonatal mice pretreated
with a limited dose of ultraviolet B irradiation. Dermatology. 189
(Suppl 1):S76–S81. 1994.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Hall RP III, Murray JC, McCord MM, Rico MJ
and Streilein RD: Rabbits Immunized with a Peptide Encoded for by
the 230-kD bullous pemphigoid antigen cDNA develop an enhanced
inflammatory response to UVB irradiation: A potential animal model
for bullous pemphigoid. J Invest Dermatol. 101:9–14.
1993.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Ho YH, Hu HY, Chang YT, Li CP and Wu CY:
Psoriasis is associated with increased risk of bullous pemphigoid:
A nationwide population-based cohort study in Taiwan. J Dermatol.
46:604–609. 2019.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Barnadas MA, Gilaberte M, Pujol R, Agustí
M, Gelpí C and Alomar A: Bullous pemphigoid in a patient with
psoriasis during the course of PUVA therapy: Study by ELISA test.
Int J Dermatol. 45:1089–1092. 2006.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Wilczek A and Sticherling M: Concomitant
psoriasis and bullous pemphigoid: Coincidence or pathogenic
relationship? Int J Dermatol. 45:1353–1357. 2006.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Danno K, Takigawa M and Horio T:
Alterations in lectin binding to the epidermis following treatment
with 8-methoxypsoralen plus long-wave ultraviolet radiation. J
Invest Dermatol. 82:176–179. 1984.PubMed/NCBI View Article : Google Scholar
|
|
40
|
George PM: Bullous pemphigoid possibly
induced by psoralen plus ultraviolet a therapy. Photodermatol
Photoimmunol Photomed. 11:185–187. 1996.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Yesudian PD, Dobson CM, Ahmad R and
Azurdia RM: Trauma-induced bullous pemphigoid around venous access
site in a haemodialysis patient. Clin Exp Dermatol. 27:70–72.
2002.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Neville JA and Yosipovitch G: Flare of
bullous pemphigoid in surgically treated skin. Cutis. 75:169–170.
2005.PubMed/NCBI
|
|
43
|
Taghipour K, Chi CC, Vincent A, Groves RW,
Venning V and Wojnarowska F: The association of bullous pemphigoid
with cerebrovascular disease and dementia: A case-control study.
Arch Dermatol. 146:1251–1254. 2010.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Langan SM, Groves RW and West J: The
relationship between neurological disease and bullous pemphigoid: A
population-based case-control study. J Invest Dermatol.
131:631–636. 2011.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Brick KE, Weaver CH, Savica R, Lohse CM,
Pittelkow MR, Boeve BF, Gibson LE, Camilleri MJ and Wieland CN: A
population-based study of the association between bullous
pemphigoid and neurologic disorders. J Am Acad Dermatol.
71:1191–1197. 2014.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Gambichler T, Segert H, Höxtermann S,
Schmitz L, Altmeyer P and Teegen B: Neurological disorders in
patients with bullous pemphigoid: clinical and experimental
investigations. J Eur Acad Dermatology Venereol. 29:1758–1762.
2015.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Kibsgaard L, Bay B, Deleuran M and
Vestergaard C: A retrospective consecutive case-series study on the
effect of systemic treatment, length of admission time, and
co-morbidities in 98 bullous pemphigoid patients admitted to a
tertiary centre. Acta Derm Venereol. 95:307–311. 2015.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Försti AK, Jokelainen J, Ansakorpi H,
Seppänen A, Majamaa K, Timonen M and Tasanen K: Psychiatric and
neurological disorders are associated with bullous pemphigoid-a
nationwide finnish care register study. Sci Rep.
6(37125)2016.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Khosravani S, Handjani F, Alimohammadi R
and Saki N: Frequency of neurological disorders in bullous
pemphigoid patients: A cross-sectional study. Int Sch Res Notices.
2017(6053267)2017.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Ravn AH, Thyssen JP and Egeberg A: Skin
disorders in Parkinson's disease: Potential biomarkers and risk
factors. Clin Cosmet Investig Dermatol. 10:87–92. 2017.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Kalińska-Bienias A, Kowalczyk E, Jagielski
P, Bienias P, Kowalewski C and Wozniak K: The association between
neurological diseases, malignancies and cardiovascular
comorbidities among patients with bullous pemphigoid: Case-control
study in a specialized Polish center. Adv Clin Exp Med. 28:637–642.
2019.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Langan SM, Hubbard R, Fleming K and West
J: A population-based study of acute medical conditions associated
with bullous pemphigoid. Br J Dermatol. 161:1149–1152.
2009.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Heelan K, Mahar AL, Walsh S and Shear NH:
Pemphigus and associated comorbidities: A cross-sectional study.
Clin Exp Dermatol. 40:593–599. 2015.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Kremer N, Zeeli T, Sprecher E and Geller
S: Failure of initial disease control in bullous pemphigoid: A
retrospective study of hospitalized patients in a single tertiary
center. Int J Dermatol. 56:1010–1016. 2017.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Hsu DY, Brieva J, Nardone B, West D and
Silverberg JI: Association of pemphigus and systemic corticosteroid
use with comorbid health disorders: A case-control study. Dermatol
Online J. 23(13030/qt1vk2m30m)2017.PubMed/NCBI
|
|
56
|
Ungprasert P, Wijarnpreecha K and
Thongprayoon C: Risk of venous thromboembolism in patients with
bullous pemphigoid: A systematic review and meta-analysis. Indian J
Dermatol Venereol Leprol. 84:22–26. 2018.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Venning VA and Wojnarowska F: The
association of bullous pemphigoid and malignant disease: A case
control study. Br J Dermatol. 123:439–445. 1990.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Bastuji-Garin S, Joly P, Lemordant P,
Sparsa A, Bedane C, Delaporte E, Roujeau JC, Bernard P, Guillaume
JC, Ingen-Housz-Oro S, et al: Risk factors for bullous pemphigoid
in the elderly: A prospective case-control study. J Invest
Dermatol. 131:637–643. 2011.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Schulze F, Neumann K, Recke A, Zillikens
D, Linder R and Schmidt E: Malignancies in Pemphigus and Pemphigoid
Diseases. J Invest Dermatol. 135:1445–1447. 2015.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Balestri R, Magnano M, La Placa M, Patrizi
A, Angileri L, Tengattini V and Bardazzi F: Malignancies in bullous
pemphigoid: A controversial association. J Dermatol. 43:125–133.
2016.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Callen JP: Internal disorders associated
with bullous disease of the skin. A critical review. J Am Acad
Dermatol. 3:107–119. 1980.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Dahl MV: Bullous pemphigoid: Associated
diseases. Clin Dermatol. 5:64–70. 1987.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Chen YJ, Wu CY, Lin MW, Chen TJ, Liao KK,
Chen YC, Hwang CY, Chu SY, Chen CC, Lee DD, et al: Comorbidity
profiles among patients with bullous pemphigoid: A nationwide
population-based study. Br J Dermatol. 165:593–599. 2011.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Ljubojevic S and Lipozenčić J: Autoimmune
bullous diseases associations. Clin Dermatol. 30:17–33.
2012.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Akarsu S, Özbağçivan Ö, Dolaş N and Aktan
Ş: Possible triggering factors and comorbidities in newly diagnosed
autoimmune bullous diseases. Turkish J Med Sci. 47:832–840.
2017.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Dainichi T and Kabashima K: Interaction of
psoriasis and bullous diseases. Front Med. 5(222)2018.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Harper EG, Guo C, Rizzo H, Lillis JV,
Kurtz SE, Skorcheva I, Purdy D, Fitch E, Iordanov M and Blauvelt A:
Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro
and in vivo: Implications for psoriasis pathogenesis. J Invest
Dermatol. 129:2175–2183. 2009.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Watad A, Bragazzi NL, Adawi M, Amital H,
Toubi E, Porat BS and Shoenfeld Y: Autoimmunity in the elderly:
Insights from basic science and clinics-a mini-review. Gerontology.
63:515–523. 2017.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Lee YI, Choi S, Roh WS, Lee JH and Kim TG:
Cellular senescence and inflammaging in the skin microenvironment.
Int J Mol Sci. 22(3849)2021.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Scott MM and Liang SY: Infections in older
adults. Emerg Med Clin North Am. 39:379–394. 2021.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Ganceviciene R, Liakou AI, Theodoridis A,
Makrantonaki E and Zouboulis CC: Skin anti-aging strategies.
Dermatoendocrinol. 4:308–319. 2012.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Raine-Fenning NJ, Brincat MP and
Muscat-Baron Y: Skin aging and menopause: Implication for
treatment. Am J Clin Dermatol. 4:371–378. 2003.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Farage MA, Miller KW, Elsner P and Maibach
HI: Intrinsic and extrinsic factors in skin ageing: A review. Int J
Cosmet Sci. 30:87–95. 2008.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Chen Y and Lyga J: Brain-skin connection:
Stress, inflammation and skin aging. Inflamm Allergy Drug Targets.
13:177–190. 2014.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Schikowski T and Hüls A: Air pollution and
skin aging. Curr Environ Health Rep. 7:58–64. 2020.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Nakyai W, Saraphanchotiwitthaya A, Viennet
C, Humbert P and Viyoch J: An in vitro model for fibroblast
photoaging comparing single and repeated UVA irradiations.
Photochem Photobiol. 93:1462–1471. 2017.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Bhatia E, Kumari D, Sharma S, Ahamad N and
Banerjee R: Nanoparticle platforms for dermal antiaging
technologies: Insights in cellular and molecular mechanisms. Wiley
Interdiscip Rev Nanomed Nanobiotechnol: Aug 22, 2021 (Epub ahead of
print).
|
|
78
|
Xi YP, Nette EG, King DW and Rosen M:
Age-related changes in normal human basement membrane. Mech Ageing
Dev. 19:315–324. 1982.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Bonté F, Girard D, Archambault JC and
Desmoulière A: Skin changes during ageing. Subcell Biochem.
91:249–280. 2019.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Waller JM and Maibach HI: Age and skin
structure and function, a quantitative approach (I): Blood flow,
pH, thickness, and ultrasound echogenicity. Ski Res Technol.
11:221–235. 2005.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Wilhelm KP, Cua AB and Maibach HI: Skin
aging. Effect on transepidermal water loss, stratum corneum
hydration, skin surface pH, and casual sebum content. Arch
Dermatol. 127:1806–1809. 1991.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Gilchrest BA, Blog FB and Szabo G: Effects
of aging and chronic sun exposure on melanocytes in human skin. J
Invest Dermatol. 73:141–143. 1979.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Trivisonno A, Rossi A, Monti M, Di Nunno
D, Desouches C, Cannistra C and Toietta G: Facial skin rejuvenation
by autologous dermal microfat transfer in photoaged patients:
Clinical evaluation and skin surface digital profilometry analysis.
J Plast Reconstr Aesthetic Surg. 70:1118–1128. 2017.PubMed/NCBI View Article : Google Scholar
|
|
84
|
Buranasirin P, Pongpirul K and Meephansan
J: Development of a global subjective skin aging assessment score
from the perspective of dermatologists. BMC Res Notes.
12(364)2019.PubMed/NCBI View Article : Google Scholar
|
|
85
|
Mine S, Fortunel NO, Pageon H and
Asselineau D: Aging alters functionally human dermal papillary
fibroblasts but not reticular fibroblasts: A new view of skin
morphogenesis and aging. PLoS One. 3(e4066)2008.PubMed/NCBI View Article : Google Scholar
|
|
86
|
Hall BM, Balan V, Gleiberman AS, Strom E,
Krasnov P, Virtuoso LP, Rydkina E, Vujcic S, Balan K, Gitlin I, et
al: Aging of mice is associated with p16(Ink4a)- and
β-galactosidase-positive macrophage accumulation that can be
induced in young mice by senescent cells. Aging (Albany NY).
8:1294–1315. 2016.PubMed/NCBI View Article : Google Scholar
|
|
87
|
Ressler S, Bartkova J, Niederegger H,
Bartek J, Scharffetter-Kochanek K, Jansen-Durr P and Wlaschek M:
p16 INK4A is a robust in vivo biomarker of cellular aging in human
skin. Aging Cell. 5:379–389. 2006.PubMed/NCBI View Article : Google Scholar
|
|
88
|
Pereira BI, Devine OP, Vukmanovic-Stejic
M, Chambers ES, Subramanian P, Patel N, Virasami A, Sebire NJ,
Kinsler V, Valdovinos A, et al: Senescent cells evade immune
clearance via HLA-E-mediated NK and CD8+ T cell
inhibition. Nat Commun. 10(2387)2019.PubMed/NCBI View Article : Google Scholar
|
|
89
|
Waldera Lupa DM, Kalfalah F, Safferling K,
Boukamp P, Poschmann G, Volpi E, Götz-Rösch C, Bernerd F, Haag L,
Huebenthal U, et al: Characterization of skin aging-associated
secreted proteins (SAASP) produced by dermal fibroblasts isolated
from intrinsically aged human skin. J Invest Dermatol.
135:1954–1968. 2015.PubMed/NCBI View Article : Google Scholar
|
|
90
|
Fligiel SE, Varani J, Datta SC, Kang S,
Fisher GJ and Voorhees JJ: Collagen degradation in
aged/photodamaged skin in vivo and after exposure to matrix
metalloproteinase-1 in vitro. J Invest Dermatol. 120:842–848.
2003.PubMed/NCBI View Article : Google Scholar
|
|
91
|
Le Page A, Khalil A, Vermette P, Frost EH,
Larbi A, Witkowski JM and Fulop T: The role of elastin-derived
peptides in human physiology and diseases. Matrix Biol. 84:81–96.
2019.PubMed/NCBI View Article : Google Scholar
|
|
92
|
Zhang Z, Zhu H, Zheng Y, Zhang L, Wang X,
Luo Z, Tang J, Lin L, Du Z and Dong C: The effects and mechanism of
collagen peptide and elastin peptide on skin aging induced by
D-galactose combined with ultraviolet radiation. J Photochem
Photobiol B. 210(111964)2020.PubMed/NCBI View Article : Google Scholar
|
|
93
|
Farage MA, Miller KW, Elsner P and Maibach
HI: Functional and physiological characteristics of the aging skin.
Aging Clin Exp Res. 20:195–200. 2008.PubMed/NCBI View Article : Google Scholar
|
|
94
|
Zhang LJ, Chen SX, Guerrero-Juarez CF, Li
F, Tong Y, Liang Y, Liggins M, Chen X, Chen H, Li M, et al:
Age-related loss of innate immune antimicrobial function of dermal
fat is mediated by transforming growth factor beta. Immunity.
50:121–136.e5. 2019.PubMed/NCBI View Article : Google Scholar
|
|
95
|
Zhang L, Guerrero-Juarez CF, Hata T, Bapat
SP, Ramos R, Plikus MV and Gallo RL: Innate immunity. Dermal
adipocytes protect against invasive Staphylococcus aureus skin
infection. Science. 347:67–71. 2015.PubMed/NCBI View Article : Google Scholar
|
|
96
|
Chambers ES and Vukmanovic-Stejic M: Skin
barrier immunity and ageing. Immunology. 160:116–125.
2020.PubMed/NCBI View Article : Google Scholar
|
|
97
|
Guimarães GR, Almeida PP, de Oliveira
Santos L, Rodrigues LP, de Carvalho JL and Boroni M: Hallmarks of
aging in macrophages: Consequences to skin inflammaging. Cells.
10(1323)2021.PubMed/NCBI View Article : Google Scholar
|
|
98
|
Low E, Alimohammadiha G, Smith LA,
Costello LF, Przyborski SA, von Zglinicki T and Miwa S: How good is
the evidence that cellular senescence causes skin ageing? Ageing
Res Rev. 71(101456)2021.PubMed/NCBI View Article : Google Scholar
|
|
99
|
Stevens NE, Cowin AJ and Kopecki Z: Skin
barrier and autoimmunity-mechanisms and novel therapeutic
approaches for autoimmune blistering diseases of the skin. Front
Immunol. 10(1089)2019.PubMed/NCBI View Article : Google Scholar
|
|
100
|
Liu Y, Li L and Xia Y: BP180 is critical
in the autoimmunity of bullous pemphigoid. Front Immunol.
8(1752)2017.PubMed/NCBI View Article : Google Scholar
|
|
101
|
Hooten J, Hall RP III and Cardones A:
Updates on the management of autoimmune blistering diseases. Skin
Therapy Lett. 19:1–6. 2014.PubMed/NCBI
|
